Core Alternative Capital’s CME Group CME Stock Holding History

Core Alternative Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.28M	Sell	17,879 -1,092	-6%	-$324K	1.56%	20
2025 Q4	$5.18M	Sell	18,971 -527	-3%	-$143K	1.43%	21
2025 Q3	$5.27M	Sell	19,498 -2,837	-13%	-$772K	1.53%	21
2025 Q2	$6.16M	Sell	22,335 -2,482	-10%	-$675K	1.68%	17
2025 Q1	$6.58M	Sell	24,817 -5,279	-18%	-$1.3M	1.58%	21
2024 Q4	$6.99M	Sell	30,096 -1,205	-4%	-$277K	1.46%	26
2024 Q3	$6.91M	Buy	31,301 +1,506	+5%	+$312K	1.34%	33
2024 Q2	$5.86M	Sell	29,795 -2,664	-8%	-$550K	1.17%	37
2024 Q1	$6.99M	Sell	32,459 -3,037	-9%	-$638K	1.25%	37
2023 Q4	$7.48M	Sell	35,496 -6,632	-16%	-$1.42M	1.28%	36
2023 Q3	$8.43M	Sell	42,128 -3,934	-9%	-$782K	1.3%	37
2023 Q2	$8.53M	Sell	46,062 -6,619	-13%	-$1.22M	1.25%	39
2023 Q1	$10.1M	Buy	52,681 +2,134	+4%	+$386K	1.35%	40
2022 Q4	$8.5M	Buy	50,547 +2,136	+4%	+$371K	1.08%	41
2022 Q3	$8.57M	Buy	48,411 +17,869	+59%	+$3.53M	1.37%	41
2022 Q2	$6.25M	Buy	30,542 +6,303	+26%	+$1.34M	1.48%	37
2022 Q1	$5.77M	Sell	24,239 -9,091	-27%	-$2.14M	1.54%	40
2021 Q4	$7.01M	Sell	33,330 -1,168	-3%	-$257K	1.41%	42
2021 Q3	$6.67M	Buy	34,498 +4,018	+13%	+$814K	1.4%	45
2021 Q2	$6.48M	Buy	30,480 +4,317	+17%	+$911K	1.51%	43
2021 Q1	$5.34M	Buy	26,163 +471	+2%	+$92.8K	1.52%	43
2020 Q4	$4.68M	Buy	25,692 +776	+3%	+$132K	1.4%	47
2020 Q3	$4.17M	Sell	24,916 -403	-2%	-$67.9K	1.42%	47
2020 Q2	$4.12M	Sell	25,319 -3,529	-12%	-$633K	1.29%	50
2020 Q1	$4.99M	Buy	28,848 +16,848	+140%	+$3.35M	1.75%	23
2019 Q4	$2.41M	Buy	+12,000	New	+$2.46M	2.21%	19

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Core Alternative Capital's CME Position: Q1 2026 in Review

Core Alternative Capital reduced its CME Group (CME) stake by 5.8% in Q1 2026, selling an estimated $324K and leaving 17,879 shares worth $5.28M. The position accounts for 1.56% of the portfolio, ranked #20.

Core Alternative Capital first reported a position in CME in Q4 2019 and has held it in 26 quarters since. The position peaked at $10.1M in Q1 2023. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Core Alternative Capital held 17,879 shares of CME Group worth $5.28M as of Q1 2026.
Core Alternative Capital sold 1,092 CME Group shares in Q1 2026, an estimated $324K.
CME Group made up 1.56% of Core Alternative Capital's portfolio in Q1 2026, its #20 holding.
Core Alternative Capital first reported a position in CME Group in Q4 2019 and has held it in 26 quarters since.
Core Alternative Capital's CME Group position peaked at $10.1M in Q1 2023.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Core Alternative Capital's 13F filing for Q1 2026, filed 30 Apr 2026.